Home > Cardiology > AHA 2020 > COVID-19 and Influenza > Fewer CV complications than expected in AHA COVID-19 Registry

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By
Prof. James de Lemos, University of Texas Southwestern Medical Center, USA
Conference
AHA 2020
Trial
AHA COVID-19 CVD Registry

The first results from the AHA COVID-19 Cardiovascular Disease (CVD) Registry revealed that in-hospital cardiovascular (CV) complications were less frequent than initially anticipated on the basis of single-centre experiences. The composite rate of CV death, myocardial infarction (MI), stroke, heart failure (HF), and shock was 8.8%.

Prof. James de Lemos (University of Texas Southwestern Medical Center, USA) explained the main objectives of the registry: 1) to accelerate the pace of COVID-19 research and improve quality, in view of the unprecedented time horizon and the need for ‘out-of the-box’ thinking for solutions; 2) to collect granular data, with over 200 unique data elements and extensive serial laboratory data; and 3) to complete case capture from the beginning of the pandemic in order to minimise selection bias and enhance generalisability. Considering the immediate need for data, the research process was disrupted and democratised, establishing a ...



Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on